Key result
Higher serum non-HDL-C was associated with higher platelet counts (281,000/μl in the highest vs 258,000/μl in the lowest quartile; P<0.001 for trend) and increased erythrocyte indices.
Why the study?
Is serum non-HDL-C associated with circulating erythrocyte and platelet indices in the adult US population?
Cross-Sectional (n=4,469)
Yes
Is serum non-HDL-C associated with circulating erythrocyte and platelet indices in the adult US population?
Absolute Event Rate: 281000% vs 258000%
p-value: p=<0.001
Higher serum non-HDL-C levels are independently associated with increased erythrocyte and platelet indices in the US adult population.
No immediate clinical implications; leaves open causal links between non-HDL-C and hematologic indices in observational data.
Whereas dyslipidemia has been associated with leukocytosis, the relationship between serum cholesterol and other hematopoietic lineages is poorly defined. Erythrocytes and platelets, anucleate cells relegated to nonspecific diffusional exchange of cholesterol with serum, have been proposed to have a distinct relationship to cholesterol from leukocytes. We examined the relationship between serum cholesterol and circulating erythrocyte/platelet indices in 4,469 adult participants of the National Health and Nutrition Examination Survey (NHANES) 2005-2006. In linear regression analyses, serum non-high density lipoprotein-cholesterol (non-HDL-C) was positively associated with mean erythrocyte number, hematocrit, hemoglobin concentration, platelet count, and platelet crit independently of age, gender, race/ethnicity, smoking, body mass index, serum folate, and C-reactive protein. The magnitude of the relationship was most marked for platelets, with lowest versus highest non-HDL-C quartile subjects having geometric mean platelet counts of 258,000/μl versus 281,000/μl, respectively (adjusted model, P < 0.001 for trend). These associations persisted in a sensitivity analysis excluding several conditions that affect erythrocyte/platelet and/or serum cholesterol levels, and were also noted in an independent analysis of 5,318 participants from NHANES 2007-2008. As non-HDL-C, erythrocytes, and platelets all impact cardiovascular disease risk, there is a need for advancing understanding of the underlying interactions that govern levels of these three blood components.
No takes yet. Share an insight, caveat, or question.
Fessler et al. (2013) conducted a cross-sectional in General population (n=4,469). Serum non-high density lipoprotein-cholesterol (non-HDL-C) vs. Lowest non-HDL-C quartile was evaluated on Mean erythrocyte number, hematocrit, hemoglobin concentration, platelet count, and platelet crit (p=<0.001). Higher serum non-HDL-C was associated with higher platelet counts (281,000/μl in the highest vs 258,000/μl in the lowest quartile; P<0.001 for trend) and increased erythrocyte indices.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: